Practice Questions Flashcards
Causes of unstable angina include all of the following except: A. ventricular hypertrophy. B. vasoconstriction. C. nonocclusive thrombus. D. inflammation or infection.
A. ventricular hypertrophy.
Which of the following is most consistent with a person presenting with unstable angina?
A. a 5-minute episode of chest tightness brought on by stair climbing and relieved by rest
B. a severe, searing pain that penetrates the chest and lasts about 30 seconds
C. chest pressure lasting 20 minutes that occurs at rest
D. “heartburn” relieved by position change
C. chest pressure lasting 20 minutes that occurs at rest
The initial manifestation of coronary heart disease in men is most commonly: A. unstable angina. B. myocardial infarction. C. intracranial hemorrhage. D. stable angina.
B. myocardial infarction.
In assessing a woman with or at risk for acute coronary syndrome (ACS), the NP considers that the patient will likely present:
A. in a manner similar to that of a man with equivalent disease.
B. at the same age as a man with similar health problems.
C. more commonly with angina and less commonly with acute MI.
D. less commonly with HF.
C. more commonly with angina and less commonly with acute MI.
Rank the following signs and symptoms in the order of most common to least common in a 60-year-old woman in the time preceding an ACS event. A. dyspnea B. anxiety C. sleep disturbance D. unusual fatigue
D. unusual fatigue
C. sleep disturbance
A. dyspnea
B. anxiety
The cardiac finding most commonly associated with unstable angina is: A. physiological split S2. B. S4. C. opening snap. D. summation gallop.
B. S4.
Which of the following changes on the 12-lead ECG do you expect to find in a patient with acute coronary syndrome? A. flattened T wave B. R wave larger than 25 mm C. ST segment deviation (>0.05 mV) D. fixed Q wave
C. ST segment deviation (>0.05 mV)
Beta-adrenergic antagonists are used in ACS therapy because of their ability to:
A. reverse obstruction-fixed vessel lesions.
B. reduce myocardial oxygen demand.
C. enhance myocardial vessel tone.
D. stabilize arterial volume.
B. reduce myocardial oxygen demand.
Nitrates are used in ACS therapy because of their ability to: A. reverse fixed vessel obstruction. B. reduce myocardial oxygen demand. C. cause vasodilation. D. stabilize cardiac rhythm.
C. cause vasodilation.
Which of the following is most consistent with a patient presenting with acute MI?
A. a 5-minute episode of chest tightness brought on by stair climbing
B. a severe, localized pain that penetrates the chest and lasts about 3 hours
C. chest pressure lasting 20 minutes that occurs at rest
D. retrosternal diffuse pain for 30 minutes accompanied by diaphoresis
D. retrosternal diffuse pain for 30 minutes accompanied by diaphoresis
Match the clinical syndrome with its pathophysiologic characteristic: unstable angina.
A. new onset of chest pain and discomfort at rest or worsening of symptoms with activities that previously did not provoke symptoms
B. predictable onset of chest pain or discomfort, usually with physical exertion
C. results from full thickness (transmural) necrosis of the myocardium and total occlusion of coronary artery
D. results from severe coronary artery narrowing, transient occlusion, or microembolization of thrombus and/or atheromatous material
A. new onset of chest pain and discomfort at rest or worsening of symptoms with activities that previously did not provoke symptoms
Match the clinical syndrome with its pathophysiologic characteristic: stable angina.
A. new onset of chest pain and discomfort at rest or worsening of symptoms with activities that previously did not provoke symptoms
B. predictable onset of chest pain or discomfort, usually with physical exertion
C. results from full thickness (transmural) necrosis of the myocardium and total occlusion of coronary artery
D. results from severe coronary artery narrowing, transient occlusion, or microembolization of thrombus and/or atheromatous material
B. predictable onset of chest pain or discomfort, usually with physical exertion
Match the clinical syndrome with its pathophysiologic characteristic: NSTEMI.
A. new onset of chest pain and discomfort at rest or worsening of symptoms with activities that previously did not provoke symptoms
B. predictable onset of chest pain or discomfort, usually with physical exertion
C. results from full thickness (transmural) necrosis of the myocardium and total occlusion of coronary artery
D. results from severe coronary artery narrowing, transient occlusion, or microembolization of thrombus and/or atheromatous material
D. results from severe coronary artery narrowing, transient occlusion, or microembolization of thrombus and/or atheromatous material
Match the clinical syndrome with its pathophysiologic characteristic: STEMI.
A. new onset of chest pain and discomfort at rest or worsening of symptoms with activities that previously did not provoke symptoms
B. predictable onset of chest pain or discomfort, usually with physical exertion
C. results from full thickness (transmural) necrosis of the myocardium and total occlusion of coronary artery
D. results from severe coronary artery narrowing, transient occlusion, or microembolization of thrombus and/or atheromatous material
C. results from full thickness (transmural) necrosis of the myocardium and total occlusion of coronary artery
Which of the following changes on the 12-lead ECG would you expect to find in a patient with history of acute transmural MI 6 months ago? A. 2-mm ST segment elevation B. R wave larger than 25 mm C. T wave inversion D. deep Q waves
D. deep Q waves
Which of the following changes on the 12-lead ECG would you expect to find in a patient with myocardial ischemia? A. 2-mm ST segment elevation B. S wave larger than 10 mm C. T wave inversion D. deep Q waves
C. T wave inversion
Thrombolytic therapy is indicated in patients with chest pain and ECG changes such as:
A. 1-mm ST segment depression in leads V1 and V3.
B. physiologic Q waves in leads aVF, V5, and V6.
C. 3-mm ST segment elevation in leads V1 to V4.
D. T wave inversion in leads aVL and aVR.
C. 3-mm ST segment elevation in leads V1 to V4.
An abnormality of which of the following is the most sensitive marker for myocardial damage? A. aspartate aminotransferase B. creatine phosphokinase (CPK) C. troponin I (cTnI) D. lactate dehydrogenase
C. troponin I (cTnI)
All of the following should be prescribed as part of therapy in ACS except: A. aspirin. B. metoprolol. C. lisinopril. D. nisoldipine.
D. nisoldipine.
You see a 54-year-old man who reports acute angina episodes with significant exertion. He is currently taking a beta blocker and clopidogrel. You consider the use of which of the following at the start of anginal symptoms?
A. an oral dose of a calcium channel blocker
B. a dose of nitroglycerin via oral spray
C. an extra dose of the beta blocker
D. a sustained-effect nitroglycerin patch
B. a dose of nitroglycerin via oral spray
Which of the following is an absolute contraindication to the use of thrombolytic therapy?
A. history of hemorrhagic stroke
B. BP of 160/100 mm Hg or greater at presentation
C. current use of warfarin
D. active peptic ulcer disease
A. history of hemorrhagic stroke
For a patient with a history of MI and who demonstrates intolerance to aspirin, an acceptable alternative antiplatelet medication is: A. ibuprofen. B. clopidogrel. C. warfarin. D. rivaroxaban.
B. clopidogrel.
Routine use of the treadmill exercise tolerance test is most appropriate for:
A. a healthy 34-year-old woman.
B. a 56-year-old man following coronary artery angioplasty who needs to establish activity tolerance.
C. an 84-year-old man with stable angina who uses a walker.
D. a 52-year-old woman with dyslipidemia and no history of ACS.
B. a 56-year-old man following coronary artery angioplasty who needs to establish activity tolerance.
According to the recommendations of the American Association of Clinical Endocrinologists, the recommended low-density lipoprotein goal for a 64-year-old man with diabetes mellitus who presented with a history of ACS 2 years ago should be less than: A. 70 mg/dL (<1.8 mmol/L). B. 100 mg/dL (< 2.6 mmol/L). C. 130 mg/dL (< 3.4 mmol/L). D. 160 mg/dL (< 4.1 mmol/L).
A. 70 mg/dL (<1.8 mmol/L).